To directly address the molecular mechanisms by which overactivation of the eIF2α phosphorylation pathway may cause AD-associated memory impairments, recent studies have tested whether genetic manipulations of eIF2α kinases in transgenic mouse models can rescue their synaptic and cognitive failures. Here, EIF2A is linked to Alzheimer disease.